New York State Common Retirement Fund’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.4M Buy
408,255
+6,409
+2% +$262K 0.03% 430
2026
Q1
$13.3M Buy
401,846
+27,272
+7% +$813K 0.02% 580
2025
Q4
$11.2M Buy
374,574
+15,757
+4% +$515K 0.01% 668
2025
Q3
$13M Buy
358,817
+25,971
+8% +$855K 0.02% 632
2025
Q2
$12M Buy
332,846
+39,567
+13% +$1.47M 0.02% 665
2025
Q1
$11.6M Sell
293,279
-6,117
-2% -$206K 0.02% 643
2024
Q4
$9.01M Buy
299,396
+239,881
+403% +$6.88M 0.01% 832
2024
Q3
$1.39M Buy
59,515
+3,346
+6% +$73.1K ﹤0.01% 1538
2024
Q2
$999K Buy
56,169
+18
+0% +$287 ﹤0.01% 1769
2024
Q1
$854K Sell
56,151
-57
-0.1% -$908 ﹤0.01% 1844
2023
Q4
$960K Buy
56,208
+663
+1% +$7.71K ﹤0.01% 1811
2023
Q3
$464K Sell
55,545
-75,934
-58% -$1.06M ﹤0.01% 2087
2023
Q2
$3.27M Buy
131,479
+61,542
+88% +$1.59M ﹤0.01% 1333
2023
Q1
$1.05M Sell
69,937
-22,514
-24% -$342K ﹤0.01% 1852
2022
Q4
$1.09M Sell
92,451
-84
-0.1% -$610 ﹤0.01% 1923
2022
Q3
$548K Buy
92,535
+321
+0.3% +$2.1K ﹤0.01% 2287
2022
Q2
$392K Sell
92,214
-178
-0.2% -$1.11K ﹤0.01% 2469
2022
Q1
$879K Sell
92,392
-203
-0.2% -$2.35K ﹤0.01% 2173
2021
Q4
$1.76M Sell
92,595
-37,306
-29% -$969K ﹤0.01% 1841
2021
Q3
$4.32M Sell
129,901
-24,165
-16% -$748K ﹤0.01% 1377
2021
Q2
$5.98M Buy
154,066
+28,837
+23% +$1.13M 0.01% 1256
2021
Q1
$6.04M Sell
125,229
-11,289
-8% -$542K 0.01% 1180
2020
Q4
$7.1M Buy
136,518
+42,018
+44% +$1.42M 0.01% 1115
2020
Q3
$2.53M Buy
94,500
+6,000
+7% +$138K ﹤0.01% 1455
2020
Q2
$1.72M Buy
88,500
+11,000
+14% +$177K ﹤0.01% 1597
2020
Q1
$763K Hold
77,500
﹤0.01% 1843
2019
Q4
$860K Sell
77,500
-3,000
-4% -$22.8K ﹤0.01% 2027
2019
Q3
$452K Sell
80,500
-100
-0.1% -$697 ﹤0.01% 2382
2019
Q2
$697K Buy
80,600
+17,500
+28% +$132K ﹤0.01% 2205
2019
Q1
$507K Buy
63,100
+17,100
+37% +$92.4K ﹤0.01% 2302
2018
Q4
$189K Sell
46,000
-19,800
-30% -$98.4K ﹤0.01% 2737
2018
Q3
$368K Hold
65,800
﹤0.01% 2560
2018
Q2
$865K Sell
65,800
-37,853
-37% -$521K ﹤0.01% 2183
2018
Q1
$1.47M Buy
103,653
+800
+0.8% +$10.2K ﹤0.01% 1809
2017
Q4
$843K Hold
102,853
﹤0.01% 2132
2017
Q3
$1.22M Hold
102,853
﹤0.01% 1911
2017
Q2
$1.03M Sell
102,853
-129,799
-56% -$1.45M ﹤0.01% 2020
2017
Q1
$2.71M Buy
232,652
+8,801
+4% +$63.2K ﹤0.01% 1505
2016
Q4
$1.04M Hold
223,851
﹤0.01% 2017
2016
Q3
$1.73M Hold
223,851
﹤0.01% 1734
2016
Q2
$1.36M Hold
223,851
﹤0.01% 1815
2016
Q1
$1.91M Hold
223,851
﹤0.01% 1615
2015
Q4
$2.67M Buy
223,851
+42,933
+24% +$542K ﹤0.01% 1484
2015
Q3
$1.82M Sell
180,918
-2,250
-1% -$33.5K ﹤0.01% 1633
2015
Q2
$3.04M Sell
183,168
-75,621
-29% -$1.2M ﹤0.01% 1638
2015
Q1
$4.01M Buy
258,789
+113,609
+78% +$1.72M 0.01% 1327
2014
Q4
$2.3M Buy
+145,180
New +$1.89M ﹤0.01% 1570

Other funds holding TGTX

New York State Common Retirement Fund's TGTX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its TG Therapeutics (TGTX) stake by 1.6% in Q2 2026, buying an estimated $262K and bringing the position to 408,255 shares worth $22.4M. The position accounts for 0.03% of the portfolio, ranked #430.

New York State Common Retirement Fund first reported a position in TGTX in Q4 2014 and has held it in 47 quarters since. 138 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • New York State Common Retirement Fund held 408,255 shares of TG Therapeutics worth $22.4M as of Q2 2026.
  • New York State Common Retirement Fund bought 6,409 TG Therapeutics shares in Q2 2026, an estimated $262K.
  • TG Therapeutics made up 0.03% of New York State Common Retirement Fund's portfolio in Q2 2026, its #430 holding.
  • New York State Common Retirement Fund first reported a position in TG Therapeutics in Q4 2014 and has held it in 47 quarters since.
  • 138 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.